Ishigami et al.26 found that patients positive for both CEA and CA19-9 had significantly higher frequencies of lymph node metastasis, deeper invasion by the tumor, lower rates of curative resection, and higher rates of hepatic metastasis. This evidence concerns the gene CEACAM5 and neoplasm.